Phase-2 Study Investigator Excited About Potential Benefits Of RTA 408 Breast Cancer Therapy Radiation Dermatitis Lotion
News
Several months ago, Irving, Texas based biotech firm Reata Pharmaceuticals announced the enrollment of the first patient in a Phase 2 dose-ranging study examining the safety, tolerability, and efficacy of ... Read more